Pfizer said it is working closely with its biotech partners to “ensure continuity and the successful transition of work.” (iStock/Getty Images Plus) As pharmas like Eli Lilly and Roche bolster their ...

Alongside a series A fundraise, OTR Therapeutics disclosed that it had acquired "a preclinical program with best-in-class potential for neurological diseases." (iStock / Getty Images Plus) Pfizer’s VC ...

Pfizer said it filed a second lawsuit against Novo Nordisk and Metsera, alleging that the Danish drugmaker's attempt to outbid Pfizer to acquire the obesity biotech is anticompetitive. The new suit ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

A proposal to crack down on China biotech dealmaking, a large Pfizer licensing deal and Astellas' roadmap made our news this week. (RomoloTavani/iStock/Getty Images ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer and ...

Pfizer now has the required regulatory approval for its $4.9 billion acquisition of obesity drug developer Metsera, but whether and when that deal closes may hinge on the outcome of two lawsuits the ...